Warning! GuruFocus detected
1 Severe warning sign
with TNYA.
Try a 7-Day Free Trial
to check it out.
What is a stock summary page? Click here for an overview.
Business Description
Tenaya Therapeutics Inc
NAICS : 541714
SIC : 2833
ISIN : US87990A1060
Description
Tenaya Therapeutics Inc is a preclinical stage biotechnology company focused on discovering, developing, and delivering curative therapies that address the underlying drivers of heart disease. It is advancing product candidates from three product platforms: gene therapy, cellular regeneration and precision medicine.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 4.52 | |||||
| Equity-to-Asset | 0.77 | |||||
| Debt-to-Equity | 0.15 | |||||
| Debt-to-EBITDA | -0.13 | |||||
| Interest Coverage | N/A |
N/A
|
N/A
| |||
| Piotroski F-Score | 1/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | 31.5 | |||||
| 3-Year EPS without NRI Growth Rate | 31.6 | |||||
| 3-Year FCF Growth Rate | 39.4 | |||||
| 3-Year Book Growth Rate | -45.8 |
Momentum Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 46.23 | |||||
| 9-Day RSI | 43.89 | |||||
| 14-Day RSI | 40.84 | |||||
| 3-1 Month Momentum % | -37.95 | |||||
| 6-1 Month Momentum % | -46.91 | |||||
| 12-1 Month Momentum % | -78.81 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 4.22 | |||||
| Quick Ratio | 4.22 | |||||
| Cash Ratio | 3.85 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -28 | |||||
| Shareholder Yield % | -44.57 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | -87.22 | |||||
| ROA % | -71.32 | |||||
| ROIC % | -175.67 | |||||
| 3-Year ROIIC % | 1231.92 | |||||
| ROC (Joel Greenblatt) % | -227.31 | |||||
| ROCE % | -84.22 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PB Ratio | 0.61 | |||||
| Price-to-Tangible-Book | 0.61 | |||||
| EV-to-EBIT | -0.57 | |||||
| EV-to-Forward-EBIT | -0.64 | |||||
| EV-to-EBITDA | -0.61 | |||||
| EV-to-Forward-EBITDA | -0.64 | |||||
| EV-to-Forward-Revenue | 8.78 | |||||
| EV-to-FCF | -0.72 | |||||
| Price-to-Net-Current-Asset-Value | 1.39 | |||||
| Price-to-Net-Cash | 1.63 | |||||
| Earnings Yield (Greenblatt) % | -175.44 | |||||
| FCF Yield % | -86.12 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:TNYA
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Tenaya Therapeutics Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | -1.32 | ||
| Beta | 2.75 | ||
| 3-Year Sharpe Ratio | -0.18 | ||
| 3-Year Sortino Ratio | -0.32 | ||
| Volatility % | 120.73 | ||
| 14-Day RSI | 40.84 | ||
| 14-Day ATR ($) | 0.097868 | ||
| 20-Day SMA ($) | 0.677905 | ||
| 12-1 Month Momentum % | -78.81 | ||
| 52-Week Range ($) | 0.3941 - 5.32 | ||
| Shares Outstanding (Mil) | 162.58 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 1 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Tenaya Therapeutics Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Tenaya Therapeutics Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Tenaya Therapeutics Inc Frequently Asked Questions
What is Tenaya Therapeutics Inc(TNYA)'s stock price today?
The current price of TNYA is $0.65. The 52 week high of TNYA is $5.32 and 52 week low is $0.39.
When is next earnings date of Tenaya Therapeutics Inc(TNYA)?
The next earnings date of Tenaya Therapeutics Inc(TNYA) is 2025-05-14 Est..
Does Tenaya Therapeutics Inc(TNYA) pay dividends? If so, how much?
Tenaya Therapeutics Inc(TNYA) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers